FDA cleared the VasQ from Laminate Medical Technologies on Oct 29, 2026 under K263598, a special 510(k). The device falls under product code QVQ, Extravascular Support For An Arteriovenous Fistula For Vascular Access, regulated at 21 CFR 870.4600 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Sep 30, 2026. The decision came 29 days later, inside the 90 FDA-day goal for a 510(k).

This is the only decision on file for Laminate Medical Technologies in the last 12 months of the tracker.